research use only
Cat.No.S7146
| Related Targets | PKC ROCK Bcr-Abl |
|---|---|
| Other TGF-beta/Smad Inhibitors | SB431542 RepSox (E-616452) Vactosertib (TEW-7197) LDN-193189 A-83-01 LDN-193189 Dihydrochloride Galunisertib (LY2157299) SRI-011381 (C381) LY2109761 SIS3 Hydrochloride |
| Cell Lines | Assay Type | Concentration | Incubation Time | Formulation | Activity Description | PMID |
|---|---|---|---|---|---|---|
| A549 | Function assay | 3 and 5 µM | 24 h | DMH1 treatment effectively blocked Smad 1/5/8 phosphorylation in a dose dependent manner | 24603907 | |
| SKOV3 | Function assay | 20 μM | 24 h | reduce the canonical phosphorylation of Smads 1,5 and 9 | 26235139 | |
| OVCAR8 | Function assay | 20 μM | 24 h | reduce the canonical phosphorylation of Smads 1,5 and 9 | 26235139 | |
| OVCAR3 | Function assay | 20 μM | 24 h | reduce the canonical phosphorylation of Smads 1,5 and 9 | 26235139 | |
| MCF-7 | Function assay | 5 μmol/L and 10 μmol/L | 24 h | completely abolished the increase of autophagy responses in MCF-7 cells | 26579463 | |
| HeLa | Function assay | 5 μmol/L and 10 μmol/L | 24 h | DMH1 inhibited CDDP-induced autophagy in HeLa cells. | 26579463 | |
| HUVECs | Function assay | 4.5 μM | 2 h | simultaneous stimulation of BMPER and BMP4 together with DMH1 prevented augmentation of NICD and HES1 on the protein level | 29473997 | |
| Click to View More Cell Line Experimental Data | ||||||
|
In vitro |
DMSO
: 25 mg/mL
(65.71 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 380.44 | Formula | C24 H20 N4 O |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 1206711-16-1 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC(C)OC1=CC=C(C=C1)C2=CN3C(=C(C=N3)C4=CC=NC5=CC=CC=C45)N=C2 | ||
| Targets/IC50/Ki |
ALK2
(Cell-free assay) 107.9 nM
|
|---|---|
| In vitro |
DMH1 inhibits BMP signaling with IC50 of 100 nM, and selectively inhibits the BMP-induced Smad1/5/8 activation. This compound increases cardiomyocyte progenitors and promotes cardiac differentiation in mouse embryonic stem cells. In addition, as a BMP inhibitor, it significantly reduces NSCLC cell growth, migration and invasion.
|
| Kinase Assay |
Kinase assay
|
|
All kinase assays are conducted by Reaction Biology Corp. In brief, this compound is tested at 10 concentrations by 3-fold serial dilutions starting at 30 μM, using nonspecific kinase inhibitor staurosporine as control. In vitro kinase reactions are carried out in the presence of 10 μM (33P)γATP. Five kinases tested are the human BMP type-I receptor activin receptor-like kinase 2 (ALK-2/ACVR1), the human TGFβ type-I receptor activin receptor-like kinase 5 (Alk5/TGFβR1), the human VEGF type-II receptor (KDR/Flk-1/VEGFR2), the human AMP-activated protein kinase (AMPK/A1/B1/G1) and the human platelet-derived growth factor receptor-β (PDGFRβ).
|
|
| In vivo |
DMH1 dorsalizes the embryonic axis without disrupting the angiogenic process in Zebrafish embryos. In proepicardial explants, this compound results in the greatest inhibition of epithelial sheet migration. This chemical (5 mg/kg i.p.) attenuates xenograft lung tumor growth in mice bearing A549 xenograft.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | Integrin β1 / p-Smad / Smad1 / p-AKT / AKT |
|
26337467 |
| Growth inhibition assay | Cell proliferation |
|
26337467 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.